Envista (NYSE:NVST) Updates FY 2025 Earnings Guidance

Key Points

• Envista has updated its FY 2025 earnings guidance, projecting an EPS of 1.050-1.15, surpassing the consensus estimate of 1.003.
• The company's stock price fell 5.4% to $18.89 during trading, with a significant trading volume of 8 million shares compared to the average of 2.6 million.
• Equities analysts have mixed ratings on Envista, with an average target price of $20.54 and a range of ratings from "sell" to "strong buy."

Envista (NYSE:NVST - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 1.050-1.15 for the period, compared to the consensus EPS estimate of 1.003. The company issued revenue guidance of -.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on NVST. UBS Group raised their price objective on shares of Envista from $18.00 to $22.00 and gave the stock a "neutral" rating in a report on Tuesday, July 29th. Baird R W upgraded shares of Envista from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, May 27th. Evercore ISI increased their price objective on shares of Envista from $19.00 to $23.00 and gave the stock an "outperform" rating in a research note on Wednesday, July 9th. Stifel Nicolaus increased their price objective on shares of Envista from $24.00 to $25.00 and gave the stock a "buy" rating in a research note on Friday. Finally, Wall Street Zen upgraded shares of Envista from a "buy" rating to a "strong-buy" rating in a research note on Saturday. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating, four have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat.com, Envista has a consensus rating of "Hold" and an average target price of $20.92.

Envista Stock Performance

Shares of Envista stock traded down $0.22 during trading on Monday, hitting $20.61. 533,048 shares of the stock were exchanged, compared to its average volume of 2,614,700. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of 64.80, a price-to-earnings-growth ratio of 1.22 and a beta of 1.00. The company has a fifty day moving average price of $19.41 and a 200-day moving average price of $18.60. Envista has a 1-year low of $14.22 and a 1-year high of $23.00. The company has a current ratio of 2.44, a quick ratio of 2.08 and a debt-to-equity ratio of 0.46.

Envista (NYSE:NVST - Get Free Report) last released its quarterly earnings data on Thursday, July 31st. The company reported $0.26 earnings per share for the quarter, topping the consensus estimate of $0.24 by $0.02. The company had revenue of $682.10 million for the quarter, compared to analyst estimates of $638.21 million. Envista had a net margin of 2.11% and a return on equity of 4.84%. Envista's revenue for the quarter was up 7.7% compared to the same quarter last year. During the same period in the previous year, the business earned $0.11 EPS. As a group, equities analysts predict that Envista will post 1 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Royal Bank of Canada grew its stake in Envista by 26.6% in the 1st quarter. Royal Bank of Canada now owns 23,240 shares of the company's stock valued at $401,000 after buying an additional 4,885 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Envista by 15.5% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 568,982 shares of the company's stock valued at $9,821,000 after buying an additional 76,246 shares during the last quarter. Goldman Sachs Group Inc. grew its stake in Envista by 39.3% in the 1st quarter. Goldman Sachs Group Inc. now owns 629,140 shares of the company's stock valued at $10,859,000 after buying an additional 177,630 shares during the last quarter. Finally, Millennium Management LLC grew its stake in Envista by 218.6% in the 1st quarter. Millennium Management LLC now owns 383,966 shares of the company's stock valued at $6,627,000 after buying an additional 263,442 shares during the last quarter.

Envista Company Profile

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.